tirzepatide week 3 update of taking (GLP-1) for my chronic pain & chronic inflammation with suspicions of diaphragmatic endometriosis (already diagnosed with Lyme disease, thoracic outlet syndrome & What to Expect on Tirzepatide:

Wegovy and Zepbound are FDA-approved for chronic weight management in people with obesity or overweight with a weight-related health condition Contact your insurance provider for details on the coverage for Ozempic by calling the phone number on the back of your insurance card to find out how much youll pay for Ozempic with insurance

This preserves the natural pulsatile release pattern and negative feedback mechanisms, typically resulting in a safer side effect profile (Prakash & Bhatt, 2013, Indian Journal of Endocrinology and Metabolism )

Chamma L, Chamma N, Mattar L, Slaybe M, Haidar S, Rizk R

When GLP1s suppress appetite, the risk of unintended muscle loss is real unless resistance training and adequate protein intake are prioritized